All articles by Pradeep Bairaboina
Pradeep Bairaboina
GeneDx expands into genetic testing for Inborn Errors of Immunity
The expansion aligns with GeneDx’s mission to enhance patient outcomes by offering exome and genome testing solutions to a wider patient base
Paragonix, Vanderbilt achieve kidney transplant milestone with KidneyVault system
Vanderbilt University Hospital becomes the first in Tennessee to implement advanced preservation technology for kidney transplantation, aiming to expand the donor pool
Monogram Technologies secures FDA approval for mBôs TKA System
The Monogram mBôs TKA System is intended to enhance safety, efficiency, and precision in robotic-assisted total knee arthroplasty
GE HealthCare launches AltiX AI.i for advanced cardiac procedures
The AltiX AI.i editions incorporate features designed to streamline processes and improve interoperability while maintaining robust cybersecurity measures
Valcare Medical’s AMEND Trans-Septal System gets FDA nod for early feasibility study
The AMEND Trans-Septal System, which features a semi-rigid, closed, D-shaped annuloplasty ring, is a transcatheter device developed to treat mitral insufficiency
C2N Diagnostics secures $10m from Samsung to advance brain health diagnostics
The funding is expected to enhance C2N’s capacity to expand its clinical laboratory services and diagnostic solutions focused on brain health
Helius Medical Technologies establishes news subsidiary Revelation Neuro
Revelation Neuro, Inc. is focused on advancing development of a non-implantable artificial intelligence (AI) powered BCI technology
Researchers invent new method for developing accurate sensors for continuous health monitoring
Researchers at the University of Turku, Finland, have succeeded in producing sensors from single-wall carbon nanotubes that are suitable for this purpose
EverGlade Consulting helps SonALAsense secure up to $46m in ARPA-H funding
The $46m in ARPA-H funding supports SolalaSense’s mission to advance a non-invasive, ultrasound-based approach for targeting and treating tumours
Baxter to divest kidney-care unit to Carlyle Group for $3.8bn
Baxter plans to use after-tax proceeds from the sale to reduce its debt, in line with its stated capital allocation priorities